Page last updated: 2024-08-25

rosiglitazone and dalcetrapib

rosiglitazone has been researched along with dalcetrapib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Derks, M; Fowler, S; Kuhlmann, O	1

Other Studies

1 other study(ies) available for rosiglitazone and dalcetrapib

Article	Year
In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates. Current medical research and opinion, 2009, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Amides; Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microsomes, Liver; Middle Aged; Rosiglitazone; Sulfhydryl Compounds; Thiazolidinediones; Young Adult	2009

Article

Year

In vitro and in vivo assessment of the effect of dalcetrapib on a panel of CYP substrates.

Current medical research and opinion, 2009, Volume: 25, Issue:4

Topics: Adolescent; Adult; Aged; Amides; Aryl Hydrocarbon Hydroxylases; Cardiovascular Diseases; Clinical Trials, Phase II as Topic; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microsomes, Liver; Middle Aged; Rosiglitazone; Sulfhydryl Compounds; Thiazolidinediones; Young Adult

2009